SCHEMBL30867191

SCHEMBL30867191

Fc1cc(F)cc(-c2nc(OCCc3c[nH]c4ccc(Cl)cc34)c3ncsc3n2)c1

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SNCA P37840 12/20 0.40
HTR2A P28223 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.39
GPR84 Q9NQS5 1/20 0.37
SLC6A4 P31645 2/20 0.36
HTR1A P08908 1/20 0.36
CDK4 P11802 1/20 0.36
CCND1 P24385 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA2B P29275 1/20 0.36
ADORA1 P30542 1/20 0.36
IP6K1 Q92551 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27320810 0.94 SNCA (0.41) SNCAHTR2ATRPM8GPR84SLC6A4
SCHEMBL30867161 0.94 SNCA (0.41) SNCAHTR2ATRPM8GPR84SLC6A4
SCHEMBL31534055 0.92 MPO (0.42) HTR2ATRPM8GPR84SLC6A4HTR1A
SCHEMBL27320817 0.92 MPO (0.42) HTR2ATRPM8GPR84SLC6A4HTR1A
SCHEMBL27319549 0.88 GSK3B (0.39) GPR84SLC6A4HTR1ACDK4CCND1
SCHEMBL31534096 0.88 GSK3B (0.39) GPR84SLC6A4HTR1ACDK4CCND1
SCHEMBL30867211 0.86 HTR1A (0.43) HTR2ATRPM8SLC6A4HTR1A
SCHEMBL27319956 0.86 HTR1A (0.43) HTR2ATRPM8SLC6A4HTR1A
SCHEMBL30867194 0.85 HPGD (0.45) SNCAHTR2ATRPM8GPR84CDK4
SCHEMBL30867170 0.85 HTR2A (0.45) SNCAHTR2ATRPM8GPR84SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598931-A1 COMPOUNDS USEFUL IN MODULATION OF AHR SIGNALLING JAGUAHR THERAPEUTICS PTE LTD (SG) 2025-08-13 EP disclosed
CN-119948035-A Compounds useful for modulating AhR signaling 捷豹治疗有限公司 2025-05-06 CN disclosed
WO-2024076300-A1 COMPOUNDS USEFUL IN MODULATION OF AHR SIGNALLING JAGUAHR THERAPEUTICS PTE LTD (SG) 2024-04-11 WO disclosed